FACET JOINT SYNDROME

This adverse event was reported 3259 times

These drugs are most commonly taken by patients reporting FACET JOINT SYNDROME:

# Drug Count
0 DICLOFENAC SODIUM 2151
1 LEFLUNOMIDE 2118
2 ALENDRONATE SODIUM 2099
3 RITUXIMAB 2099
4 DICLOFENAC 2070
5 SECUKINUMAB 2062
6 METHOTREXATE SODIUM 2048
7 TOCILIZUMAB 2037
8 ADALIMUMAB 2000
9 METHOTREXATE 1943
See all common drugs associated with FACET JOINT SYNDROME

FACET JOINT SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HYDROCORTISONE BUTYRATE 440 0.2227
1 DICLOFENAC POTASSIUM TABLETS 1345 0.1551
2 NEOMYCIN OINTMENT 360 0.1468
3 CAFFEINE CITRATE 314 0.1345
4 GOLIMUMAB 1670 0.1326
5 DICLOFENAC POTASSIUM 1345 0.1217
6 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 80 0.1216
7 CORTISONE ACETATE 1417 0.1134
8 NICOTINAMIDE 280 0.1096
9 PSEUDOEPHEDRINE HCL 1108 0.1012
See all drugs enriched for association with FACET JOINT SYNDROME

FACET JOINT SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 773 1.1235
1 Endoglycosidase [EPC] 205 0.1106
2 Interleukin-17A Antagonist [EPC] 2062 0.0553
3 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 458 0.0525
4 Provitamin D2 Compound [EPC] 1173 0.0394
5 Antirheumatic Agent [EPC] 2118 0.0200
6 Aminosalicylate [EPC] 1802 0.0179
7 Interleukin-6 Receptor Antagonist [EPC] 2100 0.0151
8 Histamine-1 Receptor Antagonist [EPC] 1220 0.0145
9 beta3-Adrenergic Agonist [EPC] 663 0.0139
See all drug classes enriched for association with FACET JOINT SYNDROME